Seqens

Ecully, France · Founded 2003 · Privately Held (backing)

Manufacturer of pharmaceutical ingredients and specialty ingredients based in Ecully, France. Seqens is based in Ecully, France and was founded in 2003. Its last reported valuation was $1.6 billion in Nov 2022. It has raised $544 million.

Last reported valuation
$1.6B
Oct 2026
Priced at
—
Total raised
$543.8M
Last round
—
What is Seqens worth?
$1.6Blast reported valuation · Oct 2026

Seqens's last reported valuation, Nov 2022. Nothing priced has surfaced since.

Free account
More of Seqens with a free account
  • ·Watch Seqens: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

Valuation timeline

0 priced rounds · 32 daily marks since · Sep 2026 – Oct 2026
▮▮
Markrounds hold their value until the next priced eventMark, today
log scale
Post-money values unlock with a free account.Unlock the axis

Membership and data by Private Market View

Seqens funding history

No rounds on record

No funding rounds for Seqens are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.

Pro members can request priority coverage with a 48-hour turnaround.

Seqens valuation

Seqens's last reported valuation was $1.6 billion in Nov 2022. No priced round, secondary trade or fund mark has surfaced since.

How Seqens's valuation is determined

Private company valuations aren’t quoted on an exchange — they’re established in moments: a priced funding round sets a post-money valuation, secondary trades print at a price per share, and SEC-registered funds holding the stock report fair-value marks in their N-PORT filings.

For Seqens, the most current credible signal sets the number and the older ones confirm it: a live secondary-market price first, then three or more recent prints, then institutional fund marks, and otherwise the last priced round, which never decays. The valuation is the last round’s post-money moved by the price change since that round, so no share count is assumed. Today it is set by last reported valuation. Question about this number? Full methodology →

Frequently asked about Seqens

What is Seqens worth?
Seqens is valued at $1.6B as of Oct 2026. Seqens's last reported valuation, Nov 2022. Nothing priced has surfaced since.
How much has Seqens raised?
Seqens has raised $543.8M in total funding across its recorded rounds.